Sarissa Capital Management »

Neurocrine Biosciences shares owned by Sarissa Capital Management

Quarter-by-quarter ownership of Neurocrine Biosciences (NBIX) shares owned by Sarissa Capital Management from 13F filings

Historical chart of Sarissa Capital Management investment in Neurocrine Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Neurocrine Biosciences held by Sarissa Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neurocrine Biosciences by Sarissa Capital Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $57M 411k 137.67
2024-03-31 $48M 346k 137.92
2023-12-31 $62M 470k 131.76
2023-09-30 $41M 366k 112.50
2023-06-30 $22M 231k 94.30